Comparison

Abexinostat European Partner

Item no. TMO-T0431-2mg
Manufacturer TargetMol
CASRN 783355-60-2
Amount 2 mg
Quantity options 100 mg 1 mL x 10 mM (in DMSO) 10 mg 1 mg 1 mL 25 mg 2 mg 50 mg 5 mg
Category
Type Molecules
Specific against other
Purity 0,9843
Citations 1. Buggy JJ, et al. Mol Y Ther, 2006, 5(5), 1309-1317.
Smiles CN(C)Cc1c(oc2ccccc12)C(=O)NCCOc1ccc(cc1)C(=O)NO
ECLASS 10.1 32169090
ECLASS 11.0 32169090
UNSPSC 12000000
Alias CRA 24781,PCI24781,PCI-24781,PCI 24781,CRA 024781
Shipping Condition Cool pack
Available
Manufacturer - Targets
HDAC
Shipping Temperature
Cool pack
Storage Conditions
-20
Molecular Weight
397.42
Description
PCI-24781 (Abexinostat (PCI24781)) is a new pan-HDAC inhibitor mainly targeting HDAC1 (Ki: 7 nM), also have moderate inhibitory for HDACs 2, 3, 6, and 10 and greater than 40-fold selectivity against HDAC8. Phase 1/2.
Pathways
Chromatin/Epigenetic|||DNA Damage/DNA Repair

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 2 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close